1. Oramed Pharmaceuticals, Inc
  2. Oramed Pharmaceuticals, Inc Ownership

Historical shareholding details of Dimensional US Targeted Value ETF holdings in Oramed Pharmaceuticals, Inc (ORMP)

Monthly changes of Dimensional US Targeted Value ETF shareholding in Oramed Pharmaceuticals, Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Dimensional Us Targeted Value Etf 23,592 0.06%
Feb 26, 2025 Dimensional Us Targeted Value Etf 23,592 0.06%
Jan 31, 2025 Dimensional Us Targeted Value Etf 12,035 0.03%
Jan 30, 2025 Dimensional Us Targeted Value Etf 11,230 0.03%
Jan 29, 2025 Dimensional Us Targeted Value Etf 11,115 0.03%
Dec 31, 2024 Dimensional Us Targeted Value Etf 9,625 0.02%
Dec 30, 2024 Dimensional Us Targeted Value Etf 9,625 0.02%
Nov 29, 2024 Dimensional Us Targeted Value Etf 6,721 0.02%
Nov 28, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Oct 31, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Oct 30, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Sep 30, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Sep 26, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Aug 30, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Aug 29, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Jul 31, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Jul 30, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Jun 28, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Jun 27, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
May 30, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Apr 30, 2024 - - 0.02%
Apr 26, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Mar 29, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Feb 28, 2024 Dimensional Us Targeted Value Etf 6,531 0.02%
Nov 07, 2023 Dimensional Us Targeted Value Etf 0 0.00%
Oct 31, 2023 Dimensional Us Targeted Value Etf 1,526 0.00%
Sep 29, 2023 Dimensional Us Targeted Value Etf 1,526 0.00%
Aug 30, 2023 Dimensional Us Targeted Value Etf 1,526 0.00%
Jul 31, 2023 Dimensional Us Targeted Value Etf 1,526 0.00%

View all ownership details of Oramed Pharmaceuticals, Inc